Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-13 Sale |
2022-05-17 5:12 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
131,650 | $10.45 | $1,375,564 | 2,155,930 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:47 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
160,901 | $10.39 | $1,671,824 | 2,287,580 (Direct) |
View |
| 2022-05-05 Sale |
2022-05-09 6:58 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
86,677 | $10.37 | $898,921 | 2,448,481 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 7:30 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
270,675 | $10.38 | $2,809,332 | 2,535,158 (Direct) |
View |
| 2022-04-27 Sale |
2022-04-29 5:50 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
190,026 | $10.38 | $1,972,579 | 2,805,833 (Direct) |
View |
| 2022-04-22 Sale |
2022-04-26 6:40 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
129,781 | $10.39 | $1,347,796 | 2,995,859 (Direct) |
View |
| 2022-04-19 Sale |
2022-04-21 8:54 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
547,734 | $10.41 | $5,700,491 | 3,125,640 (Direct) |
View |
| 2021-04-27 Purchase |
2021-04-29 6:44 pm |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
450,000 | $15 | $6,750,000 | 2,759,791 (Direct) |
View |
| 2020-08-11 Purchase |
2020-08-12 9:00 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
200,000 | $15 | $3,000,000 | 3,673,374 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-27 Conversion |
2021-04-29 6:44 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
39,827,381 | $0 | 2,759,791 (Direct) |
View |
| 2021-04-22 Other |
2021-04-26 7:11 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
1,359,799 | $0 | 1,359,799 (Direct) |
View |
Ownership |
2021-04-22 8:05 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
0 | $0 | 2,208,334 (Direct) |
View |
| 2020-08-11 Conversion |
2020-08-12 9:00 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
28,371,348 | $0 | 3,673,374 (Direct) |
View |
Ownership |
2020-08-06 9:03 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
0 | $0 | 3,473,374 (Direct) |
View |